Valeant

Page 5 of 12

Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Senate Calls for Former Valeant CFO to Testify at Hearing

By
April 26, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Health

Valeant Has Named Joseph Papa its New CEO

By
April 25, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant Talking to Investment Banks to Weigh Asset Sales

By
April 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Valeant’s CEO Just Avoided Contempt Charges From the U.S. Senate

By
April 13, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Finance

Valeant Says It Has Received a Notice of Default

By
April 12, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant Asks CEO Pearson to Cooperate With U.S. Senate Committee

By
April 11, 2016
Valeant To Buy Bausch & Lomb For $8.7 Billion
Finance

Why Bill Ackman and Valeant Should Suck It Up and Sell Bausch & Lomb

By
April 8, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Hints Who Valeant’s Next CEO Will Be

By
April 6, 2016
Squawk Box - Season 20
Finance

Bill Ackman Is About to Get Seriously Grilled by Unhappy Investors

By
April 6, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

This Is Why Valeant’s Shares Are Soaring

By
April 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Sex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force

By
April 5, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Here’s Why Moody’s Just Downgraded Valeant

By
April 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Can’t Sell Valeant Even If He Wants To

By
March 31, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Valeant Is Asking its Lenders for More Time to File its Annual Report

By
March 30, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s CEO Will Have to Testify at a U.S. Congressional Hearing

By
March 28, 2016

Most Popular